New pill could mean the end of injections

Nov 28, 2016 | | Say something

MS New pill could spell the end of MS injections

Multiple sclerosis (MS) could soon take a simple pill twice a day instead of injections.

Some 35,000 people around the world are already using a drug called Tecfidera and now is licensed in the UK.

Tests have found that the drug is able to lower the rate of MS relapses by 50 percent and delay progression of the disease for the fifth.

The drug was originally developed to treat psoriasis skin disease, but scientists discovered that by making slight modifications that could create a product suitable for patients with MS.

Related Post:   Children who take ADHD drugs may have reduced bone density

Belinda Weller, a neurologist consultant Anne Rowling Regenerative Neurology Clinic in Edinburgh, said no one is quite sure how the drug works, but their results can not be discussed with.

added that many patients hate being injected and this medicine is something they have been asking for.

The drug will cost around £ 17,900 per year, which is similar to existing treatments.

About 95 percent of people with relapsing-remitting told the MS Society who wanted an alternative to daily injections when surveyed in 2010.

Michelle Mitchell, CEO charity, said the licensing Tecfidera is very good news for patients.

Related Post:   Number insulin takes triple in two decades

“effective as injectable treatments may be, the reality is that regular injections are not an attractive prospect, and many people experience reactions injection, which can be unpleasant,” she said.

“We hope that the advisory bodies of the NHS to announce its decision on whether treatment should be freely available in the coming months.”

MS is a progressive disease that attacks nerve cells. Today is incurable and affects more than 100,000 people in the UK.

For reasons not fully understood, the condition is more common in women and the average age of onset is 32.

Related Post:   MIT scientists design a device that delivers drugs directly into the pancreatic tumor

Last September, a study by the University of Dundee found that the number of people diagnosed with the disease was reduced at a rate of percent per year in the two decades until 2010.

This article was originally published on barchester, Read the original article here

You may also like:

Posted in: Diseases & Conditions

Leave a Reply

Your email address will not be published. Required fields are marked *

==[Click 2x to Close X]==
Most Popular Today!

Sorry. No data so far.